[Research Advances of K-ras Mutation in the Prognosis and Targeted Therapy of Gastric Cancer].

Y Huang,J Wei,B R Liu
DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2016.02.001
2016-01-01
Abstract:K-ras mutations have been described in 30% of human cancers with significantly different mutation frequencies. High K-ras mutation frequency is found in many cancers such as pancreas and lung cancers, whereas, gastric cancer has a relatively low K-ras mutation frequency. In recent years, numerous researches have focused on the K-ras mutation in gastric cancer. This review summarizes the K-ras mutation frequency in gastric cancer, the relationship of K-ras mutation with clinicopathologic features and prognosis of gastric cancer patients, targeted therapy for K-ras mutated gastric cancer, some small-molecular inhibitors of K-ras, and development of targeted therapy drugs for K-ras signaling pathway in gastric cancer.
What problem does this paper attempt to address?